|Articles|May 2, 2017
WIRB-Copernicus Group Acquires ThreeWire
WIRB-Copernicus Group announces the acquisition of ThreeWire.
Advertisement
WIRB-Copernicus Group announces the acquisition of ThreeWire, a global patient recruitment, enrollment and retention firm that assists biopharma, medical device companies and CROs achieve trial enrollment and retention goals.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg
2
Using AI and Tokenized Data to Match Patients to Protocols
3
Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity
4
ACT Brief: Data Strategy, AI Integration, and Rare Disease Milestones Drive Clinical Innovation
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
